Repeated epidemics caused by extended-spectrum beta-lactamase-producing Serratia marcescens strains

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 17, Issue 9, 1998, Pages 629-636

  Luzzaro, F ^a   Perilli, M ^b   Migliavacca, R ^a   Lombardi, G ^a   Micheletti, P ^a   Agodi, A ^c   Stefani, S ^c   Amicosante, G ^b   Pagani, L ^a  

^a UNIVERSITY OF PAVIA   (Italy)

^b UNIVERSITY OF L'AQUILA   (Italy)

^c UNIVERSITY OF CATANIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAMASE; CEPHALOSPORIN DERIVATIVE; MONOBACTAM DERIVATIVE;

ANTIBIOTIC RESISTANCE; ARTICLE; BIOCHEMISTRY; CLINICAL ARTICLE; ENTEROBACTER INFECTION; ENZYME SYNTHESIS; EPIDEMIC; GENE AMPLIFICATION; HUMAN; INTENSIVE CARE; ITALY; PLASMID; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SERRATIA MARCESCENS; STRAIN DIFFERENCE;

BETA-LACTAMASES; CROSS INFECTION; DISEASE OUTBREAKS; DRUG RESISTANCE, MICROBIAL; HUMANS; INTENSIVE CARE UNITS; ISOELECTRIC POINT; ITALY; MICROBIAL SENSITIVITY TESTS; PLASMIDS; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; SERRATIA INFECTIONS; SERRATIA MARCESCENS;

EID: 0032406394     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/s100960050146     Document Type: Article

References (26)

1. 1. Bennett PM, Chopra I: Molecular basis of β-lactamase induction in bacteria. Antimicrobial Agents and Chemotherapy (1993) 37:153-158
2. 2. Curtis NAC, Eisenstadt RL, Rudd C, White AJ: Inducible type I β-lactamase of gram-negative bacteria and resistance to β-lactam antibiotics. Journal of Antimicrobial Chemotherapy (1986) 17:51-61
3. 3. Livermore DM: Clinical significance of β-lactamase induction and stable derepression in gram-negative rods. European Journal of Clinical Microbiology (1987) 6:439-445
4. 4. Sanders CC, Sanders WE: β-Lactam resistance in gram-negative bacteria: global trends and clinical impact. Clinical Infectious Diseases (1992) 15:824-839
5. 5. Knothe H, Shah P, Krcmery V, Anatal M, Mitsuhashi S: Transferable resistance to cefotaxime, cefoxitin, cefamandole and cefuroxime in clinical isolates of Klebsiella pneumoniae and Serratia marcescens. Infection (1983) 11:315-317
6. 6. Sirot D, Sirot J, Labia R, Morand A, Courvalin P, Darfeuille-Michael A, Perroux R, Clunzel R: Transferable resistance to third-generation cephalosporins in clinical isolates of Klebsiella pneumoniae: identification of CTX-1, a novel β-lactamase. Journal of Antimicrobial Chemotherapy (1987) 20:323-334
7. 7. Thomson KS, Sanders CC, Washington JA II: High-level resistance to cefotaxime and ceftazidime in Klebsiella pneumoniae isolates from Cleveland, Ohio. Antimicrobial Agents and Chemotherapy (1991) 35:1001-1003
8. 8. Pagani L, Ronza P, Giacobone E, Romero E: Extended-spectrum β-lactamases from Klebsiella pneumoniae strains isolated at an Italian hospital. European Journal of Epidemiology (1994) 10:533-540
9. 9. Jacoby GA, Medeiros AA: More extended-spectrum β-lactamases. Antimicrobial Agents and Chemotherapy (1991) 35:1697-1704
10. 10. Bush K, Jacoby GA, Medeiros AA: A functional classification scheme for β-lactamases and its correlation with molecular structure. Antimicrobial Agents and Chemotherapy (1995) 39:1211-1233
11. 11. Livermore DM: β-Lactamase in laboratory and clinical resistance. Clinical Microbiological Reviews (1995) 8:557-584
12. 12. Gianneli D, Tzelepi E, Tzouvelakis LS, Mentis AF, Nikolopolou C: Dissemination of cephalosporin resistant Serratia marcescens strains producing a plasmidic SHV type β-lactamase in Greek hospitals. European Journal of Clinical Microbiology & Infectious Diseases (1994) 13:764-767
13. 13. Payne DJ, Marriot MS, Amyes SGB: Plasmid mediated ceftazidime resistance identified in a strain of Serratia marcescens isolated in Belgium. Journal of Antimicrobial Chemotherapy (1992) 27:689-692
14. 14. Pagani L, Luzzaro F, Ronza P, Rossi A, Micheletti P, Porta F, Romero E: Outbreak of extended-spectrum β-lactamase producing Serratia marcescens in an intensive care unit. FEMS Immunology and Medical Microbiology (1994) 10:39-46
15. 15. Perilli MG, Felici A, Franceschini N, De Santis A, Pagani L, Luzzaro F, Oratore A, Rossolini GM, Knox JR, Amicosante G: Characterization of a new TEM-derived β-lactamase produced in a Serratia marcescens strain. Antimicrobial Agents and Chemotherapy (1997) 41:2374-2382
16. 16. National Committee for Clinical Laboratory Standards: Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard M7-A4. NCCLS, Villanova, PA (1997)
17. 17. Jarlier V, Nicolas M-H, Fournier G, Philippen A: Extended broad-spectrum β-lactamases conferring transferable resistance to newer β-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns. Reviews of Infectious Diseases (1988) 10:867-878
18. 18. Hanahan D, Jessee J, Bloom FR: Techniques for transformation of E. coli. In: Glover DM, Hames BD (eds) DNA cloning 1 : a practical approach. Oxford University Press, Oxford (1995) pp. 1-35
19. 19. Domenico P, Marx JL, Schoch PE, Cunha BA: Rapid plasmid DNA isolation from mucoid gram-negative bacteria. Journal of Clinical Microbiology (1992) 30:2859-2863
20. 20. Matthew M, Harris AM, Marshall MJ, Ross GW: The use of isoelectric focusing for detection and identification of betalactamases. Journal of General Microbiology (1975) 88:169-178
21. 21. Mabilat C, Courvalin P: Development of "oligotyping" for characterization and molecular epidemiology of TEM β-lactamases in members of the family Enterobacteriaceae. Antimicrobial Agents and Chemotherapy (1990) 34:2210-2216
22. 22. Mabilat C, Goussard S, Sougakoff W, Spencer RC, Courvalin P: Direct sequencing of the amplified structural gene and promoter for the extended-broad-spectrum β-lactamase TEM-9 (RHH-1) of Klebsiella pneumoniae. Plasmid (1990) 23:27-34
23. 23. Kidd KK, Ruano G: Optimizing PCR. In: McPherson MJ, Hames BD, Taylor GR (eds): PCR 2:a practical approach. Oxford University Press, Oxford (1995) pp. 1-22
24. 24. Privitera O, Agodi A, Puntorieri M, Primavera A, Santagati M, Privitera A, Mezzatesta ML, Giuffrida E, Stefani S: Molecular epidemiology of enterococci with high-level resistance to aminoglycosides. Microbial Drug Resistance (1995) 1:293-297
25. 25. Miranda G, Kelly C, Solorzano F, Leanos B, Coria R, Patterson JE: Use of pulsed-field gel electrophoresis typing to study an outbreak of infection due to Serratia marcescens in a neonatal intensive care unit. Journal of Clinical Microbiology (1996) 34:3138-3141
26. 26. Shi ZY, Liu PYF, Lau YJ, Lin YH, Hu BS: Use of pulsed-field gel electrophoresis to investigate an outbreak of Serratia marcescens. Journal of Clinical Microbiology (1997) 35:325-327